Elisa Bellini

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism.

M. Tampellini, A. Pia, M. Torta, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.